In hepatocellular carcinoma, the down-regulation of miR-1301 expression can up-regulate the expression of its target gene BCL9 and activate the Wnt/β-catenin signaling pathway, thereby inhibiting the migration, invasion, EMT, and angiogenesis of hepatocellular carcinoma (19). The gene discussed is BCL9; the disease is hepatocellular carcinoma.